Design
Review
Authors
Loading...
May guide cGMP-targeted therapies in vascular and hypertrophic disease; leaves open clinical validation in prospective trials.
Key points are not available for this paper at this time.
Pilz et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: